대장암 및 린치 증후군 분야의 선도적 전문가인 C. 리처드 볼랜드 박사(MD)는 40년 이상의 경력을 바탕으로 유전성 대장암에 관한 중추적 연구 성과와 미국 위장병학회(AGA) 회장직을 포함한...
▶⏸
2. 유전성 대장암, 린치 증후군 진단. 1
대장암 유전학 및 린치 증후군 분야의 선도적 전문가인 C. 리처드 볼랜드 박사(MD)가 이 유전적 상태가 어떻게 암 발병 위험을 높이는지, 유전자 검사를 통한 조기 발견의...
▶⏸
3. Colon cancer symptoms. Colorectal cancer signs. 2
Dr. C. Richard Boland, MD, explains the often silent symptoms of colon cancer, differences between proximal and distal tumor presentations, and how regular screening prevents...
▶⏸
4. Familial colon cancer. Colorectal cancer genetic cause. 3
Dr. C. Richard Boland, MD, explains how familial colon cancer syndromes develop through different genetic pathways, including Lynch syndrome, adenomatous polyposis, and rare conditions like...
▶⏸
5. Familial colon cancer. Age of onset. How to prevent hereditary colon cancer? 4
Dr. C. Richard Boland, MD, explains how hereditary colon cancer develops earlier than sporadic cases due to inherited gene mutations, why family history and biomarkers...
▶⏸
6. Colorectal cancer prognosis. Epigenetics. DNA methylation importance. 5
Dr. C. Richard Boland, MD, explains how DNA methylation drives 30-40% of cancers through silencing tumor suppressor genes, with specific focus on the CpG Island...
▶⏸
7. Colorectal cancer prognosis. DNA methylation and microRNA levels predict cancer survival. 6
Dr. C. Richard Boland, MD, explains how DNA methylation patterns and microRNA levels serve as powerful biomarkers for predicting cancer prognosis and personalizing treatment. His...
▶⏸
8. Colorectal cancer. Precision medicine therapy. Microsatellite Instability. 7
Dr. C. Richard Boland, MD, explains how microsatellite instability (MSI) impacts treatment selection and prognosis in colon cancer. He details how 15% of colorectal tumors...
▶⏸
9. Colorectal Cancer Immunotherapy. Keytruda. Pembrolizumab. 8
Dr. C. Richard Boland, MD, explains how microsatellite instability (MSI) testing transforms treatment selection, why immune checkpoint inhibitors like Keytruda (pembrolizumab) outperform chemotherapy for MSI-high...
▶⏸
10. Colorectal cancer and inflammation. Ulcerative colitis and cancer risk. 9
Dr. C. Richard Boland, MD, explains how chronic inflammation dramatically increases cancer risk throughout the digestive system, particularly in conditions like ulcerative colitis, primary sclerosing...
▶⏸
11. Viral infection and colorectal cancer. 10
Dr. C. Richard Boland, MD, explores the potential link between viral infections and colon cancer development, discussing the JC virus hypothesis, research challenges, and why...
Dr. C. Richard Boland, MD, explains how curcumin—the active compound in turmeric—reduces inflammation and may prevent colon cancer. Research shows populations consuming 300 mg daily...
▶⏸
13. 암 화학요법 정밀의학: 계산된 치료. 제1부. 12
암 유전학 및 정밀의학 분야의 선도적 전문가 C. 리처드 볼랜드 박사(MD)가 수학적 모델링을 활용한 계산항암요법이 어떻게 종양 내성을 극복하고 대장암, 흑색종, 췌장암의 완치율을 높이는지 설명합니다....
▶⏸
14. Cancer chemotherapy precision medicine. Calculated treatment. Part 2. 13
Dr. C. Richard Boland, MD, explains how mathematical modeling transforms chemotherapy selection from trial-and-error to precision-calculated treatment, using tumor proliferation rates, death rates, and mutation...
▶⏸
15. Colorectal cancer tumor markers. Cancer therapy efficacy prediction. 14
Dr. C. Richard Boland, MD, explains how the miR-21 microRNA tumor marker revolutionizes colon cancer screening and prognosis. This blood-based biomarker helps identify high-risk patients...
▶⏸
16. Colorectal cancer screening. MicroRNA in blood and feces. How to find early colon cancer. 15
Dr. C. Richard Boland, MD, explains how microRNA biomarkers in blood and fecal samples offer a promising non-invasive method for early colon cancer detection. He...
▶⏸
17. “Cancer Family: the search for the cause of hereditary colorectal cancer”. Book by Dr. C. Richard Boland. 16
Dr. C. Richard Boland, MD, shares his personal journey uncovering the genetic cause of Lynch syndrome in his family. His book details how early-onset colon...
<의료 전문가 패널>을 통해 귀하의 사례에 가장 적합한 의료진이 치료 계획을 세심하게 맞춤 구성합니다.
